BRPI0511095B8 - um processo para produção de enantiômero de anlodipino em alta pureza ótica - Google Patents

um processo para produção de enantiômero de anlodipino em alta pureza ótica

Info

Publication number
BRPI0511095B8
BRPI0511095B8 BRPI0511095A BRPI0511095A BRPI0511095B8 BR PI0511095 B8 BRPI0511095 B8 BR PI0511095B8 BR PI0511095 A BRPI0511095 A BR PI0511095A BR PI0511095 A BRPI0511095 A BR PI0511095A BR PI0511095 B8 BRPI0511095 B8 BR PI0511095B8
Authority
BR
Brazil
Prior art keywords
optical purity
high optical
enantiomer
producing amlodipine
amlopidine
Prior art date
Application number
BRPI0511095A
Other languages
English (en)
Inventor
Baburao Manikrao Bhawal
Rajendra Dagadu Deshmukh
Milind Moreshwar Gharpure
Satish Ramanlal Mehta
Prasad Vasudeo Ranade
Original Assignee
Emcure Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emcure Pharmaceuticals Ltd filed Critical Emcure Pharmaceuticals Ltd
Publication of BRPI0511095A publication Critical patent/BRPI0511095A/pt
Publication of BRPI0511095B1 publication Critical patent/BRPI0511095B1/pt
Publication of BRPI0511095B8 publication Critical patent/BRPI0511095B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

um processo para produção de enantiômero de anlodipino em alta pureza ótica, a presente invenção se relaciona a um processo para preparação de solvato (s)-anlodipino-l-hemitartarato dmf oticamente puro compreendido das etapas de tratar base (r,s)-anlodipino com ácido l-tartárico na presença de dimetilformamida e um co-solvente. a invenção também se relaciona a um processo para conversão de solvato (r) ou (s)-anlodipino-l-hemitartarato dmf em seus besilatos sem isolamento da base quiral livre de anlodipino após a solução.
BRPI0511095A 2004-10-20 2005-10-17 um processo para produção de enantiômero de anlodipino em alta pureza ótica BRPI0511095B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1123/MUM/2004 2004-10-20
IN1123MU2004 2004-10-20
PCT/IB2005/003108 WO2006043148A1 (en) 2004-10-20 2005-10-17 Process for producing enantiomer of amlodipine in high optical purity

Publications (3)

Publication Number Publication Date
BRPI0511095A BRPI0511095A (pt) 2007-12-26
BRPI0511095B1 BRPI0511095B1 (pt) 2021-01-19
BRPI0511095B8 true BRPI0511095B8 (pt) 2021-05-25

Family

ID=35708803

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511095A BRPI0511095B8 (pt) 2004-10-20 2005-10-17 um processo para produção de enantiômero de anlodipino em alta pureza ótica

Country Status (11)

Country Link
US (2) US7858801B2 (pt)
EP (1) EP1802576B1 (pt)
JP (1) JP4932728B2 (pt)
KR (1) KR101130622B1 (pt)
AT (1) ATE399154T1 (pt)
BR (1) BRPI0511095B8 (pt)
DE (1) DE602005007763D1 (pt)
ES (1) ES2307209T3 (pt)
PT (1) PT1802576E (pt)
RU (1) RU2376288C2 (pt)
WO (1) WO2006043148A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0500570A3 (en) * 2005-06-08 2008-03-28 Richter Gedeon Nyrt Process for the preparation of (s)-(-)-amlodipine
KR100913791B1 (ko) * 2006-07-21 2009-08-26 한미약품 주식회사 (ｓ)-(-)-암로디핀 캠실레이트 또는 이의 수화물 및 이를함유하는 약학적 조성물
WO2008026838A1 (en) * 2006-08-30 2008-03-06 Chemtech Research Incorporation Method for preparing an optically active amlodipine
KR100828883B1 (ko) * 2006-10-27 2008-05-09 씨제이제일제당 (주) 라세믹 암로디핀으로부터 ｓ-(-)-암로디핀의 분리방법
CN101773500B (zh) * 2010-02-09 2012-05-23 施慧达药业集团(吉林)有限公司 抗高血压的药物组合物
CN101766611B (zh) * 2010-02-09 2011-10-12 施慧达药业集团(吉林)有限公司 一种左旋氨氯地平或其可药用盐和β受体阻滞剂的药物组合物及其应用
KR101313842B1 (ko) * 2010-09-15 2013-10-01 대화제약 주식회사 에스-암로디핀 베실레이트 및 그 수화물의 제조방법
CN111689894B (zh) * 2019-03-13 2023-05-02 鲁南制药集团股份有限公司 一种苯磺酸左旋氨氯地平晶型
CN112110850B (zh) * 2019-06-20 2023-05-02 鲁南制药集团股份有限公司 一种苯磺酸左旋氨氯地平新晶型
CN110882249B (zh) 2019-11-08 2021-04-30 北京吾为尔创科技有限公司 含苯磺酸左氨氯地平水合物的组合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804630D0 (en) 1988-02-27 1988-03-30 Pfizer Ltd Preparation of r-& s-amlodipine
AU3147593A (en) * 1991-11-26 1993-06-28 Sepracor, Inc. Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
US6057344A (en) * 1991-11-26 2000-05-02 Sepracor, Inc. Methods for treating hypertension, and angina using optically pure (-) amlodipine
GB9317773D0 (en) * 1993-08-26 1993-10-13 Pfizer Ltd Therapeutic compound
GB9405833D0 (en) * 1994-03-24 1994-05-11 Pfizer Ltd Separation of the enantiomers of amlodipine
CN1100038C (zh) * 2000-02-21 2003-01-29 张喜田 氨氯地平对映体的拆分
CZ2004531A3 (cs) * 2001-10-24 2004-10-13 Sepracorźáinc Způsob štěpení amlodipinového racemátu
US20030176706A1 (en) * 2002-03-18 2003-09-18 Joshi Rohini Ramesh Process for the preparation of [S(-) amlodipine - L (+)- hemitartarate]
EP1348697A1 (en) 2002-03-28 2003-10-01 Council Of Scientific & Industrial Research Process for the preparation of S(-)-amlodipine-L(+)-hemitartrate
KR100476636B1 (ko) 2002-09-11 2005-03-17 한림제약(주) 엘-(+)-타르트레이트를 이용한 에스-(-)-암로디핀의 제조방법
EP1407773A1 (en) 2002-10-08 2004-04-14 Council of Scientific and Industrial Research A process for the preparation of s (-) amlodipine salts
US6608206B1 (en) * 2002-10-30 2003-08-19 Council Of Scientific & Industrial Research Process for making S(-) Amlodipine salts
CN1882543A (zh) * 2003-11-20 2006-12-20 科学与工业研究委员会 制备手性氨氯地平盐的方法

Also Published As

Publication number Publication date
BRPI0511095A (pt) 2007-12-26
KR101130622B1 (ko) 2012-04-02
KR20070062946A (ko) 2007-06-18
EP1802576B1 (en) 2008-06-25
US20110021783A1 (en) 2011-01-27
US8445688B2 (en) 2013-05-21
PT1802576E (pt) 2008-09-15
RU2006138705A (ru) 2008-05-10
EP1802576A1 (en) 2007-07-04
WO2006043148B1 (en) 2006-06-08
DE602005007763D1 (de) 2008-08-07
WO2006043148A1 (en) 2006-04-27
ES2307209T3 (es) 2008-11-16
US7858801B2 (en) 2010-12-28
US20080262239A1 (en) 2008-10-23
JP2008517050A (ja) 2008-05-22
BRPI0511095B1 (pt) 2021-01-19
RU2376288C2 (ru) 2009-12-20
JP4932728B2 (ja) 2012-05-16
ATE399154T1 (de) 2008-07-15

Similar Documents

Publication Publication Date Title
BRPI0511095A (pt) um processo para produção de enantiÈmero de anlodipino em alta pureza ótica
EP2343275A3 (fr) Procédé de préparation et forme cristalline I des énantiomères optiques du modafinil.
ATE546423T1 (de) Verfahren zur herstellung von alkyl(meth)acrylaten
EA200900536A1 (ru) Способ получения хиральных 8-(3-аминопиперидин-1-ил) ксантинов
DE60329527D1 (de) Verfahren zur herstellung von photochromischen kontaktlinsen
BR0107425A (pt) Processo para a preparação compostos de derivados de ácido 3-hidróxi picolìnico e uso dos compostos
ATE544754T1 (de) Verfahren zur herstellung von ivabradinhydrochlorid
NO20053089D0 (no) Carbamidsyreestere med anticolinergisk virkning.
DE60229194D1 (de) Verfahren zur Herstellung von Acrylsäure
DE602004027229D1 (de) Verfahren zur herstellung von photonischer kristallfaser
ATE485273T1 (de) Verfahren zur optischen auftrennung von amlodipin
DE502005007702D1 (de) Verfahren zur herstellung von terrylen-3,4:11,12-t
DK1440947T3 (da) Fremgangsmåde til fremstilling af en optisk fiber præform og en optisk fiber præform og en optisk fiber fremstillet ved fremgangsmåden
ATE445601T1 (de) Verfahren zur herstellung von carvedilol und seinen enantiomeren
DE60320201D1 (de) Verfahren zur Herstellung von optischen Polyimid-Wellenleitern.
BRPI0513881A (pt) processo para a preparação de compostos opticamente ativos
ATE310772T1 (de) Verfahren zur ueberfuehrung von perylen-3,4:9, 10-tetracarbonsaeurediimiden in eine fuer die anwendung als fluoreszenzfarbmittel geeignete form
DE50101601D1 (de) Verfahren zur herstellung eines brillenglases
DE602004021605D1 (de) Verfahren zur herstellung von enantiomerenreinem mirtazapin
DE60126744D1 (de) Verfahren zur herstellung von 2-hydroxy-4-methylthio-buttersäure-estern
ATE428707T1 (de) Verfahren zur herstellung des (s)-enantiomers von omeprazol
ATE466010T1 (de) Verfahren zur herstellung von candesartan
DE602004019523D1 (de) Verfahren zur herstellung von optisch aktivem chroman-carbonsäureester
ATE555093T1 (de) Verfahren zur herstellung einer (s)-1-alkyl-2i,6i-pipecoloxylididverbindung
DE602006002650D1 (de) Verfahren zur Herstellung von Paroxetin Hydrochlorid Hemihydrat

Legal Events

Date Code Title Description
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/01/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/10/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF